Manufacturer
Novartis
Contents
Per capsule contains Indacaterol 110mcg, glycopyrronium 50mcg. Each delivered dose (via mouthpiece of the inhaler): Indacaterol 85mcg, glycopyrronium 43mcg
Indication
Maintenance bronchodilator treatment to relieve symptoms in adult patients with Chronic Obstructive Pulmonary Disorder.
Instruction
Recommended Dose: One capsule once daily.
Ultibro Breezhaler is recommended to be administered at the same time daily. If a dose is missed, it should be taken as soon as possible on the same day. Patients should be instructed not to take >1 dose daily.
Drug interaction
May weaken or antagonise β2-adrenergic agonists effect. Anticholinergics. May potentiate adverse events w/ sympathomimetic agents & possible hypokalaemic effect w/ methylxanthine derivatives, steroids or non-K-sparing diuretics.
Malaysia
